Trademark: 87424800
Word
KBI BIOPHARMA
Status Date
Monday, June 5, 2023
Registration Number
5339610
Registration Date
Tuesday, November 21, 2017
Filing Date
Tuesday, April 25, 2017
Published for Opposition
Tuesday, September 5, 2017
40 contract manufacturing in the field of biopharmaceuticals
42 contract biopharmaceutical drug development services
The mark consists of three disk-shaped objects connected by a diagonal line. The term "KBI" above the term "BIOPHARMA" is displayed in uppercase letters to the right of the disk-shaped objects.
Color is not claimed as a feature of the mark.
"BIOPHARMA"
Jun 5, 2023
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jun 5, 2023
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jun 5, 2023
Case Assigned To Post Registration Paralegal
Nov 28, 2022
Teas Section 8 & 15 Received
Nov 21, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 9, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 9, 2020
Teas Change Of Correspondence Received
Oct 9, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 9, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 9, 2020
Teas Change Of Owner Address Received
Nov 21, 2017
Registered-Principal Register
Sep 5, 2017
Official Gazette Publication Confirmation E-Mailed
Sep 5, 2017
Published For Opposition
Aug 16, 2017
Notification Of Notice Of Publication E-Mailed
Jul 28, 2017
Assigned To Lie
Jul 25, 2017
Approved For Pub - Principal Register
Jul 25, 2017
Examiner's Amendment Entered
Jul 25, 2017
Notification Of Examiners Amendment E-Mailed
Jul 25, 2017
Examiners Amendment E-Mailed
Jul 25, 2017
Examiners Amendment -Written
Jul 20, 2017
Assigned To Examiner
May 3, 2017
Notice Of Design Search Code E-Mailed
May 2, 2017
New Application Office Supplied Data Entered
Apr 28, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
